The University of Chicago Header Logo

Connection

Seleeke Flingai to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Seleeke Flingai has written about Breast Neoplasms.
Seleeke Flingai
Connection Strength
0.045
Breast Neoplasms
  1. A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther. 2014 Aug; 25(8):730-9.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.